secwatch.observer — SEC 8-K summary
======================================

Issuer:     9 METERS BIOPHARMA, INC. (—)
CIK:        0001551986
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0000930413-23-001864
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 2.04, 1.03, 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

9 Meters Biopharma files Chapter 7 bankruptcy, ceases operations, Nasdaq delisting July 26
--------------------------------------------------------------------------------

- Filed Chapter 7 bankruptcy petition on July 17, 2023; Chapter 7 trustee appointed to liquidate assets.
- All operations ceased; all officers (including interim CEO/CFO Bethany Sensenig) and board members resigned effective immediately.
- Nasdaq notified delisting; trading suspended at opening on July 26, 2023; company will not appeal.
- Bankruptcy triggered defaults on all debt; partial acceleration of $1.08M paid to High Trail Special Situations, $1.6M remains outstanding.
- Forbearance agreement terminated upon bankruptcy filing; no further operations or employees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551986/000093041323001864/0000930413-23-001864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551986/000093041323001864/c106716_8k-ixbrl.htm
  HTML page:      https://secwatch.observer/filing/0000930413-23-001864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer